Calcium antagonists.
D000787:Angina Pectoris / Q000188:drug therapy; D002121:Calcium Channel Blockers / Q000378:metabolism / Q000494:pharmacology* / Q000627:therapeutic use; D002462:Cell Membrane / Q000187:drug effects / Q000378:metabolism; D004110:Diltiazem / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use; D006321:Heart / Q000187:drug effects*; D006801:Humans; D006973:Hypertension / Q000188:drug therapy; D009119:Muscle Contraction / Q000187:drug effects; D009131:Muscle, Smooth, Vascular / Q000187:drug effects; D009200:Myocardial Contraction / Q000187:drug effects; D009203:Myocardial Infarction / Q000188:drug therapy; D009206:Myocardium / Q000378:metabolism; D009543:Nifedipine / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use; D010480:Perhexiline / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use; D014700:Verapamil / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use
D002121:Calcium Channel Blockers; D014700:Verapamil; D004110:Diltiazem; D009543:Nifedipine; D010480:Perhexiline